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ABSTRACT 
Process validation is an essential component for the safety of drug product and also to maintain the quality of the product. Process 
validation is the fundamental component for assuring the quality system used by pharmaceutical industries. Process validation is 
the key element to assure the identity, purity, safety, efficacy and also maintaining the quality of final product. The Process 
validation precisely focused on the aim, method of analysis, and knowledge. The Process validation establishes the flexibilities and 
limitations which are faced during the manufacturing process; the variables are controlled for attaining the desired attributes, 
which assures a consistency in quality of product throughout the product life. In this article an overview is given on process 
validation with special reference to tablet. 
Key-words: Process validation, good manufacturing practices (GMP), Critical Process Parameter 
 
INTRODUCTION 
The main aim of the designing a dosage form is to get 
the predictable medicinal responses of the drug from 
the dosage form. The product should be a quality 
product, the quality assessment is the most important 
part for any product, the product should confirm all the 
criteria given in the pharmacopoeia; it should be 
reproducible when manufactured in large scale. For the 
assurance of quality, there a lot of features are required, 
which are related to chemical and physical stability of 
drug and formulation, preservation from microbial 
contamination, content uniformity of drug and should 
be well accepted by the physicians and patients
1
. 
Building quality in the product is a most convincing 
concept, rather than testing the final product, quality 
cannot be assured by testing in-process or finished 
product,
2
 therefore each and every step of product 
manufacturing should be controlled to achieve the 
predetermined design and quality attributes including 
specification. Therefore each and every step should be 
performed and validated.      
Validation is essential part of good manufacturing 
practices (GMP). Validation is therefore, an element of 
quality assurance which confirms the quality of 
product, equipment, manufacturing steps, and 
analytical test procedures.
3
 From the economic point of 
view validation is very important it helps in decreasing 
the rejection and retesting, which minimized the waste 
and cost. Validation is prerequisite for product 
approval from various regulatory bodies like USFDA 
and CGMPs, Validation can be for a process, 
equipment and analytical method.  
When we validate a set of all  individual step of 
manufacturing, this is known process validation. 
Process validation is assuring and documenting the 
process within their specified and designed criteria, 
therefore the manufactured product will meet its 
predetermined criteria and quality attributes with 
reproducible and constant result
2
. In 1970’s FDA 
officials Ted Byers and Bud Loftus have given the 
concept of validation for improving the quality of 
pharmaceuticals. In present scenario, validation is the 
prerequisite for pharmaceutical industry which is much 
talked subject and done by almost all pharmaceutical 
companies.  
A tablet comes under solid dosage forms. The 
manufacturing of solid dosage forms involves 
extensive powder handling. A series of unit operation 
are involved in manufacturing of tablet which include 
powder blending for content uniformity and converted 
into solid mass form either through wet granulation or 
direct compression. Various unit operation are used 
which include weighing, sieving, dry mixing/blending, 
wet mixing drying milling and sieving, blending, 
compression coating and packing. Therefore a lot of 
error may arise in each step, for minimizing those 
errors, the process should be validated.   
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Definition of validation: Action of proving in 
accordance with the principles of Good Manufacturing 
Practice, that any procedure, process equipment, 
material, activity, or system actually leads to the 
expected result
4
. 
USFDA defined process validation as “A documented 
evidence which provides high degree of assurance that 
a specific process will consistently produce a product 
meeting its predetermined specification and quality 
characteristics”5.  
We can perform the process validation:- 
1. For new product in which trail batch, development 
batch are manufactured.  
2. Products produced at the sending site or 
transferred product 
3. The original product before revalidation. 
Why process validation is required? 
6,7 
 
The process validation is very essential for 
pharmaceutical industry. There are various reasons for 
performing process validation, which include: 
1.  For New product or existing products if there are 
any changes as per SUPAC. 
2.  If the manufacturing site is changed. 
3.  If the batch size, equipment and the manufacturing 
process of existing products is to be changed. 
4.  If the composition or components and critical 
control parameters are to be changed. 
5.  If the vendor of API or critical excipient is to be 
changed. 
6.  If the quality parameters shows any abnormality in 
Annual Product Review (APR). 
7.  If there is trend of OOS or OOT is observed in next 
batches. 
TYPES OF PROCESS VALIDATION 
8,9 
1. Prospective validation  
2. Concurrent validation 
3. Retrospective validation 
4. Revalidation  
Prospective validation  
The Prospective validation is executed before 
commercialization of product, it is performed before or 
during the development of either a new product or in 
changing production process, the risk and errors that 
may arise during production are check out, these 
changes may have a significant effect on the properties 
of the product. It is a predetermined scientific approach 
having a validation protocol which include steps of 
process development, sampling plan, batch record, 
specifications for API/ excipient/packaging material, 
pilot runs, transfer of technology from scale-up to 
commercialized batch, list of all processes to be 
performed with  environmental controls like 
temperature and humidity.
8
 
1. The validation batch size should be up to 10times 
of the representative development batch. 
2. In general practice in pharmaceutical industries 
first three batches which meet the set specification 
of product quality considered for prospective 
validation before marketing. 
3. The process should include identification and 
evaluation of individual steps, identification of 
critical situations, design of trial plans and set of 
priorities, performance of trial, recording result, 
assessment and evaluation of observed results. 
Concurrent validation: A process can be monitored 
by monitoring processing steps of a finished product or 
the process validation is done in ongoing process. In 
different batches the quality of product may vary. 
Some of the conditions are given here:  
1.  If a prevalidated process is transferred to a third 
party contract manufacturer or shifting to any other 
manufacturing unit. 
2.  If a product of different strength from a 
prevalidated batch having the same ratio of 
active/inactive ingredient is to be changed.  
3.  If a small volume batch is needed for production or 
on market demand.  
4.  In case of urgent supply is needed due to shortage. 
5.  If there any deviation is arises the justification 
should be documented approved by validation team. 
6.  If any adverse reaction is seen in concurrent 
validation a proper plan for handling of the marketed 
product should be there.  
7.  The 3 consecutive batches are acceptable for study. 
Retrospective validation: Retrospective validation is 
performed for a product already in the market, and it is 
based on the historical data to establish a process 
validation. This may be performed for the old product 
which was not prevalidated by the manufacturer earlier 
and now to be validated to confirm the requirements of 
regulatory bodies. Some of the necessary components 
are given below:  
a) Batch size/strength/manufacturing year/period. 
b) MMR and BPR documents. 
c) A complete list of deviations and its rectification 
measures and changes to manufacturing 
documents. 
d) Stability testing data of different batches. 
e) All analytical method to be used. 
In retrospective validation 20 batches should be 
considered, if the batches are more than 20, the data 
obtained from at least 20 last consecutive batches must 
be taken and if batches are less than 20 all batches are 
taken. This validation is rarely used nowadays because 
any existing product is not subjected to the prospective 
validation. This is performed only for the audit 
purpose. Rejected batches are not included in this 
validation.  
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Re-Validation: The need of re-validation is arises 
when there is any critical process parameter, 
formulation, packaging material, excipient, equipment 
and building is changed. If the product get failed to 
meet the specifications in batches, this require re-
validation. Re-Validation becomes essential in some 
condition; there few conditions are given below where 
re-validation is required. 
1. In case raw materials to be changed 
(physicochemical properties that may affect the 
process or product). 
2. In case the vendor of API/excipient/ packaging 
materials is to be changed. 
3. In case the packaging material is to be changed 
(primary container/closure system). 
4. In case the process variables are (e.g., mixing time, 
drying temp. and batch size) to be changed.  
5. If the equipment is to be changed (e.g. addition of 
automatic detection system). 
6. If the plant/facility is to be changed. 
7. Variations revealed by trend analysis (e.g. process 
drifts). 
APPROACHES FOR PROCESS VALIDATION 
9.10.11,12
 
In process validation a series of unit operations are 
conducted throughout the lifecycle of the product and 
process. There different approaches are used in process 
validation recommended by USFDA, ICH and CPV. 
There are three stages are recommended by USFDA in 
process validation.
9
 
Stage 1–Process Design: In process design the 
manufacturing process for commercialization is 
defined on the basis of previous knowledge of 
development and scale-up activities.  
Stage 2–Process Qualification: In process 
qualification the capability of producing reproducible 
results on commercialization of manufacturing process 
is determined by evaluating process design.  
Stage 3–Continued Process Verification: In 
continuous process verification the concurrent 
assurance is obtained during the routine production 
which is remains in a state of control. 
Second approach is recommended by ICH; according 
to ICH guideline three things are considered, which 
include Pharmaceutical development (ICH Q8 (R2), 
Quality Risk Management (ICH Q9) and 
Pharmaceutical Quality System (ICH Q10). 
According to ICH guideline the pharmaceutical 
development is done. During the development of a 
product and its manufacturing process, information is 
generated from the scientific approaches and quality 
risk management. Pharmaceutical development (ICH 
Q8) is done for the marketing application and can be 
updated to support new information obtained over the 
lifecycle of a product. A complete knowledge of 
product and manufacturing process is obtained for 
reviewers and inspectors. Pharmaceutical and 
manufacturing sciences give an idea about regulatory 
flexibility. The regulatory flexibility is based on 
relevant scientific information. It is programmed that 
the manufacturing process should provide a quality 
product with consistency in performance as determined 
previously. The information which is obtained from 
development studies and experiences, gives the 
scientific understanding for establishing designing 
space, criteria, and process controls. This Information 
may be a used for the quality risk management (ICH 
Q9). The quality cannot be tested into products. 
Quality should be built in by design. The changes in 
formulation and manufacturing process, at the time of 
development and lifecycle management may be used to 
get information and can be used to establish in space 
designing. From the experiments and unexpected 
results, the relevant information is obtained which 
should be included. According to this guideline, to 
understand the role and impact of attributes and 
parameter on product or in- process material, all 
attributes and parameter should be checked and re-
evaluated to make new information. Those attributes 
tell about the degree of control on risk to the process 
and output, the higher degree of control is appropriate 
for attributes that pose higher risk. Pharmaceutical 
Quality System ICH (Q10) is the management 
responsibility; it is used to prepare quality policy, 
quality planning and resource management.
  
 
 
 
 
 
 
                                                    
 
 
Figure 1: showing relationship between Q8, Q9 and Q10 
ICH Q9  
Quality Risk 
Management 
 
ICHQ8  
Pharmaceutical 
Development  
ICH Q10 
Pharmaceutical 
Quality System 
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Continuous Process Verification is an alternative 
approach to the traditional validation, where the 
manufacturing process is continuously monitored and 
tested, this is science and risk based on real time 
approach to verify and demonstrate that a process that 
operates within the predefined specified parameters 
consistently produce material which meet all its critical 
quality attributes and quality strategy requirements. It 
is recommended that the industry should perform 
suitable in-line or at-line controls and the performance 
and quality of product monitored regularly. 
1. The quality attributes of raw material or in-process 
and finished material should be collected, 
including verification of attributes, parameters, 
and end point, the CQA and the critical process 
parameters should be assessed.  
2. Process analytical technology application like NIR 
spectroscopy with or without feedback loop(e.g. 
end point determination, blend uniformity, granule 
surface area, assay) and multiple statistical process 
control can also view for continuous process 
verification validation  
Identification of Critical Process Parameter
9
 
The critical process parameters are identified with the 
help of process capability. Process capability is defined 
as the studies to determine critical process parameters 
or operating variables which influences the process 
output and also the range of numerical data. These 
studies result in acceptable output. For manufacturing 
of any dosage form certain process is used and some 
process capability qualification is considered as given 
below:  
1. Specification, testing methods and acceptance 
criteria related to raw materials 
2. The basic rational for using excipients 
3. Quantitative formula of final product 
4. Specification, testing methods and acceptance 
criteria related finished product 
5. Details of instrument and apparatus to be used for 
preparing a batch size in 10time multiplication. 
6. The stability reports of finished product. 
7. Process Flow diagram showing details of each 
stage in logical manner with excipient added, 
control variable, major equipment and test 
parameters for each process variable. 
For finding out the critical process parameters the 
study of process characterization and process ranging 
with performance qualification is done. In process 
characterization different methods are used to find out 
critical parameter process or test parameter include 
cause and effect shown by fish bone diagram, 
constraint analysis Pareto principle etc, process ranging 
is the study to find out critical process or test parameter 
and their respective control limits which will also 
affect the quality and consistency of product 
(outcomes/attribute). A brief discussion on fish bone 
diagram and constrain analysis will be relevant here. 
 
1. Fish bone diagram9 
Let us consider a tablet manufacturing process, all the 
steps are as follows: 
1. Preblending (Mixing of API and excipient)  
2. Granulation 
3. Drying 
4. Milling 
5. Blending 
6. Compression 
Step1: Preblending: The factor could influence the 
preblending processes are: 
a) Speed of Propeller/blades 
b) Load in the mass mixer 
c) Total mixing Time 
Step 2- Granulation: The factors which could 
influence the granulation process are: 
a) Load of mixture 
b) Rate of oscillation/ rotation 
c) Speed 
d) Time 
Step 3: Drying: The factors which could influence the 
drying are: 
a) Temp 
b) Size for drying 
c) Time for drying 
Step 4: Milling: The factors which could influence the 
Milling are: 
a) Mesh size of screen 
b) Speed of oscillation/rotation  
Step5: Mixing/ lubrication   
a) Load in blender 
b) Speed of rotation 
c) Time 
Compression  
a) Force of die 
b) Speed of machine 
All the factors can be shown by fish bone diagram
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Figure 2: Process flow diagram for process validation of tablet 
 
This diagram shows the relationship and 
interrelationship which may exist between various 
process variable and single response i.e. product 
attributes. The centre line of fish bone diagram is 
composite of all factors which may affect the quality 
and consistency of all finished product. The branches of 
central line show the influence of process steps. The 
process variables for each step which can cause the 
variation in the final product have been shown as 
subbranches. When the experimentation is done the 
variables are varied within the operational range and the 
results are evaluated, if the result have no significant 
deviation the variable are called non critical.  
(ii) Constraint Analysis: If we dealing with various 
variables, problems can arise there, constraints analysis 
aimed at limiting the operational range of each process 
variable and or specification limits.  
The constraint analysis the information obtained from 
previous work and experiment regarding the process, 
equipment, raw material and packaging vendors or the 
published literature is used.
 9
 
(iii) The Pareto Principle: Pareto has given a 20-80 
rule according which 80% of variation in a statistical 
sample is caused by 20% input variable. Means if we 
get 80% deviation in final result this is caused by only 
20% of process variables.
9
    
PREREQUISITE OF PROCESS VALIDATION
 7 
Prior to initiating validation studies, and it is necessary 
to assure that the equipment to be used in validation is 
functioning properly and working within the given 
range. The equipment should comply the qualification, 
according to WHO GMP. The validation qualification 
should be established and documented. The process 
development designer reviews the design qualification 
(DQ) of premises, utilities and process according to 
GMP. He also reviews weather the utilities and 
equipment are installed according to Installation 
qualification IQ and performing according to their 
performance qualification (PQ) or operating according 
to their operational qualification (OQ). He also reviews 
the reports of product development, pilot scale, scale up 
batch, the proposed master formula of product to be 
manufactured. He also confirms that the analytical 
method is made available to the plant or not before 
performing validation testing and routine testing; with 
QC/QA. The designee also prepares the production 
records of Commercial/ exhibit batch, including control 
and operational limits and plan for process control 
based on development report. Then process validation is 
conducted after validating the facilities, utilities, and 
equipment, and laboratory test methods and released for 
process validation activities. Where compendia method 
is used only limited analytical method validation shall 
be conducted. The specifications of raw materials and 
packaging materials should be approved by QC and 
vendor. The equipments and instruments should be 
calibrated. All the SOPs should be placed properly. The 
training should be given to the worker regarding the 
equipments, operations, manufacturing instruction and 
sampling plan.   
Steps in Process Validation
13 
Step 1: Identification of critical parameters of major 
processes to be validated. 
Step 2: Identify the methodology, processes, and piece 
of equipment that will be used in the manufacture of the 
products. 
Step 3: Identify the potentially relevant and critical 
process variables.  
Step 4: Conduct process validation experiments. 
Step 5: Review product performance against the 
proposed specification. After describing the quality 
features, which must be achieved in the product and the 
minimum acceptable values of each feature, the 
specifications developed for the product should be 
reviewed. 
Step 6: Monitor and review the results of the validation 
experiments. Validation report will be prepared. 
Optimized values of process variables will be assigned 
based on those validations experiments for subsequent 
running production which will give the confidence that 
the each unit operations/sub processes will lead to 
produce products of pre-defined quality consistently 
over time. 
 
Pre-blending Drying Blending 
Granulation Sizing Compression 
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Validation Protocol 
9 
For performing the process validations the detailed 
protocols are required for ensuring that the process is 
been adequately validated. The protocol should contain 
the following components: 
1. The purpose and scope of the validation. 
2. Validation team with their qualifications and 
responsibilities. 
3. Type of validation: Prospective, Concurrent, 
Retrospective, Re-validation. 
4. Total Number batches should be validated. 
5. A complete list of equipments and apparatus to be 
used; with their parameters. 
6. Installation Qualification and Operation 
Qualification of equipments. 
7. The calibration criteria for all instruments. 
8. All possible critical process parameters with their 
criteria. 
9. All the process variables/ attributes with their risk 
and management should be given. 
10. Production related all processing details should be 
clearly described in the form of master documents. 
11. Sampling schedule with all details of sampling 
points, methods and sampling plans. 
12. Statistical tools to be used in the analysis of data. 
13. Training schedule for operators. 
14. Validated test methods to be used in in-process 
testing and for the finished product. 
15. Specifications for raw and packaging materials and 
test methods. 
16. All performs for documenting the results, 
conclusions and for approval of study results 
should be given. 
 
Organization for validation and its duties
 
Validation is responsibility of an organization, various 
department are engaged in this organization   the team 
member are selected from R and D, production, QC, 
QA engineering and validation expert who can head this 
organization. The job of his team/organization is 
preparation of V M P, designing and implementation of 
validation procedures as per validation protocol, 
coordination with equipment vendors and assist in 
process fabrication and prepare appropriate reports for 
approvals, identification of turnover of validated 
systems and process, preparation of project schedules 
and implement protocols for validation, development of  
test method, conducting calibration on validation test 
equipments and processes and also preparation of  
reports to submit to management. 
 
Validation Master Plan
13  
The WHO GMP explains that all the content of 
validation program should be clearly mentioned and 
documented in validation master plans, it is an 
internally approved plan, which include validation 
policies, structure of organization, summary of facilities 
like list of equipments to be used, steps used in 
validation, formats for documentation, sampling 
schedules, process variable, change control, analytical 
method to be used, acceptance criteria, references and 
validation option (prospective, concurrent and 
retrospective validations as well as revalidation). The 
information not to be repeated documented elsewhere 
but should refer to existing documents such as policy 
documents, SOP’s and validation protocols and reports. 
The format and content should include: 
1.   Introduction: Scope of validation, 
2.  Validation policies of manufacturer, aimed to 
implementation of GMP requirement in the        country 
where the plant is located or countries where the 
product is to be exported. 
3.  Organizational structure of all activities including 
personnel responsibility, validation protocol, validation 
work, document preparation, reports, approval at every 
step and training. 
4.  Extent of validation required (IQ,OQ and or PQ) 
5.  Re-validation frequencies 
6.  Summary of facilities, list of equipments and 
complete description of process. 
7.  Complete description of product  
8.  Specific process considerations that are critical and 
those requiring extra attention. 
9.  Re-validation activities, actual status and future 
planning. 
10. Method of analysis and acceptance criteria 
11. Documentation format. 
12. References existing document  
13. List of all relevant SOPs. 
14. Time plans of each validation project and sub-
project. 
 
Sampling Schedule for Validation 
14,15
 
For validation, a detailed sampling Schedule or plan is 
required, which contain an idea about the sampling 
pattern, sampling time, method of analysis and also the 
monitory method. 
a) This plan contains a detail about sampling point, 
total no. of sample to be taken; sampling frequency 
at every unit operation, these are decided on basis 
of properties of product and equipments used in 
validation.  
b) Appropriate no. the samples should be there. 
c) At least 3 samples from each sampling point should 
be withdrawn for the statistical confidence of 
quality both within a batch and between batches. 
d) In case of blend sample on case to case basis, 
sampling size can be increased from 1to10 time As 
per USFDA, which provided on scientifically 
justified.  
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e) The location from where the samples to be 
withdrawn from any equipment should be clearly 
indicated with the help of diagram. 
Acceptance Criteria  
The acceptance criteria are the parameter that clearly 
defines the activity and limits of acceptance. The 
acceptance criteria are the specification given in official 
books like IP/USP. The test results obtained from 
validation studies evaluated against the acceptance 
criteria or specifications, the conformance is discussed 
to support the validation activities. The all results are 
evaluated for consistency and reproducibility and meet 
with predetermined attributes. A validation report is 
prepared on basis the results obtained from study 
conducted as per approved validation protocol.  
Basic Steps for validation and acceptance criteria for 
tablet
16 
While performing the validation of tablet dosage form 
we have to first know all the steps, equipment, 
apparatus used with their process variables, assessment 
parameter and acceptance criteria involved in 
validation. The all above stated things are performed 
accordingly and the data are recorded. Here all possible 
processing steps, assessment parameter and acceptance 
criteria are given in tabular form to understand how the 
validation is performed. 
 
Table 1: Steps involved in validation and acceptance criteria for tablet
 
 
Failure and Deviation
 11 
In process validation test has been performed to 
determine failure and deviation. There should not any 
case of failure. The procedure should cover all the 
possible areas of potential failure. The validation study 
gives an idea on the action to be done, recording its 
justification and recommendations. This decision 
consider: if the analytical results are not within limit, 
retesting is required. The operation parameters, process 
steps, equipment, procedure may be changed. 
Suspension of the process validation exercise until 
further technical evaluation and/or development has 
been carried out, sampling regime, analytical procedure 
and process validation acceptance criteria can be 
changed. 
Final Process Validation Report 
15 
A document in which the records, results and 
evaluation of a completed validation programmer are 
assembled and summarized. It may also contain 
S. 
N. 
Steps Control variable Assessment parameter                                         Acceptance criteria 
1 Shifting Mesh size 1.Material retention 
2. Sieve integrity (before and after) 
Entire material should pass 
through specified mesh 
Sieve should be intact 
without any damage  
2 Dry  Mixing 
Mass mixture/ 
RMG 
Time Blend uniformity  The individual result 
should be in the limit as  
specified  in  monograph 
Impeller/chopper speed Slow/medium/high For information only  
3 
 
Binder 
Preparation  
Mixing time 
Temp. Solvent used 
Check the Consistency Color of 
binder 
For information only 
4 Binder Addition Mixing time, Impeller 
speed 
Check the consistency of wet mass  For information only  
5 Granulation  
Mass mixture or 
RMG 
Mixing time Slow/medium/high For information only  
Impeller speed Slow/medium/high For information only 
Impeller load  For information only 
6 Wet Milling  
Multi-mill  
Time, speed, load   Sieve integrity (before and after) Sieve should be intact 
without any damage  
7 Drying 
Tray dryer/FBD 
Time and Temp. Inlet/outlet/ Temp./LOD Moisture content 
8 Sifting And 
Milling 
Mesh size  Particles size  Sieve should be intact 
without any damage 
9 Lubrication 
 
Time and Speed 
(Slow/medium/high) 
Blend uniformity, Bulk density, 
tapped density, Hausner ratio, 
Compressiblity index,  assay 
As specified in reference 
book (IP/USP) 
10 Compression Speed pressure 
Slow/medium/high 
Av. Wt , Thickness, Hardness, D.T 
Friability, assay, Dissolution 
As specified in reference 
book (IP/USP) 
11 Packing Forming pressure, 
Sealing Temp, Forming  
Temp, Machine speed 
Leak test, Label matter, Stereo, 
impression, Defected 
Yield at packaging stage  
As per specification  
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proposal for improvement of process. At the 
conclusion of validation activities, a final report should 
be prepared. This report should summarize and 
reference all protocols and results. It should derive 
conclusions regarding the validation status of the 
process and necessary recommendation for routine 
process. The final report should be reviewed and 
approved by the validation team and appropriate 
management. 
APPLICATION OF PROCESS VALIDATION  
Validation is basically good business practice. It helps 
in following:- 
1. Regulatory Requirement  
Validation is regulatory requirement for the cGMPs 
and USFDA all over the world. The cGMP basically 
serve as guidelines but do not provide step-by-step 
directions on how to achieve them. However, the 
validation master plan and associated SPOs exactly 
responsibilities: who, when, where, and how much is 
sufficient to demonstrate. Improve employee 
awareness of processes. 
2. Quality Assurance 
Validation provides confidence in the quality of 
product of products manufactured as the over quality of 
a particular process cannot be established due to the 
limited sample size. Validation leads to less 
troubleshooting with routine production. As a result it 
reduces the number of customer complaints and drug 
recalls. 
3. Cost Cutting Tool  
Validation is a tool for cutting the cost; it is comprised 
of preventive, appraisal, internal failure external 
failure. The preventive cost includes quality planning, 
vendor approval, training, documentation and 
preventive maintenance, calibration and sanitation cost. 
The Appraisal cost include inspection of raw material 
in-process material, finished product and stability 
testing, the internal failure cost include re-inspection, 
retesting, rework, and rejection and external failure 
cost include recall, complaints and return due to quality 
issue. Validation leads to the optimization of processes 
and results in minimization of those expenses. 
Reduction in rejections and reworks. Reduction in 
utility cost. Avoidance of capital expenditures. 
4. Reproducibility  
The product obtained from process validation shows 
reproducibility in quality, purity, strength and also 
shows consistency in results.  
5. Easier scale-up from development work. 
6. Easier maintenance of equipment. 
7. Improve employee awareness of processes. 
8. More rapid automation. 
CONCLUSION 
Validation is not only for a regulatory requirement of 
cGMP or audits across the world, but it also improve 
whole process by which an industry save time, wastage 
of investment. The process validation not only 
improves process but it also assured that the process 
will be performed in prescribed pattern and which is 
been controlled to attain and manage the quality of 
final product. Process validation is systematic approach 
in identifying, measuring, evaluation; documenting and 
revalidating the critical steps in pharmaceutical 
dosages form (tablet), with control assure consistency 
in the quality of final product. With the help of this 
review one can conduct the process validation and one 
can know basic about the process validation of in an 
industry. 
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